[Federal Register: August 14, 2006 (Volume 71, Number 156)]
[Notices]               
[Page 46514-46515]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr14au06-94]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 31, 2006, Applied 
Science Labs, Division of Alltech Associates Inc., 2701 Carolean 
Industrial Drive, State College, Pennsylvania 16801, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of the basic classes

[[Page 46515]]

of controlled substances listed in Schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
4-Methylaminorex (cis isomer) (1590).......  I
Alpha-Ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
2, 5-dimethoxy-4-n)-                         I
 propylthiophenethylamine (2C-T-7) (7348).
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
2,5-Dimethoxyamphetamine (7396)............  I
2-5-Dimethoxy-4-ethylamphetamine (7399)....  I
3,4-Methylenedioxyamphetamine (7400).......  I
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)...  I
4-Methoxyamphetamine (7411)................  I
Alpha-methyltryptamine (AMT) (7432)........  I
Bufotenine (7433)..........................  I
Diethyltryptamine (7434)...................  I
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
5-methoxy-N-,N-diisopropyltryptamine (5-MeO- I
 DIPT) (7439).
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
1-(1-Phenylcyclohexyl)pyrrolidine (PCPy)     I
 (7458).
1[1-(2 Thienyl)cyclohexyl] piperidine        I
 (7470).
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Methamphetamine (1105).....................  II
1-Phenylcylohexylamine (7460)..............  II
Phencyclidine (7471).......................  II
Phenylacetone (8501).......................  II
1-Piperidinocyclohexanecarbo nitrile (8603)  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Meperidine intermediate-B (9233)...........  II
Morphine (9300)............................  II
Noroxymorphone (9668)......................  II
------------------------------------------------------------------------

    The company plans to manufacture high purity drug standards used 
for analytical application only in clinical, toxicological and forensic 
laboratories.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than October 13, 2006.

    Dated: July 26, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E6-13221 Filed 8-11-06; 8:45 am]

BILLING CODE 4410-09-P